BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11313987)

  • 1. Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity.
    Barette C; Jariel-Encontre I; Piechaczyk M; Piette J
    Oncogene; 2001 Feb; 20(5):551-62. PubMed ID: 11313987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Diehl JA; Zindy F; Sherr CJ
    Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.
    Cayrol C; Ducommun B
    Oncogene; 1998 Nov; 17(19):2437-44. PubMed ID: 9824154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
    Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
    Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
    Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
    J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the mediator subunit cyclin C and its implications for CDK8 function.
    Hoeppner S; Baumli S; Cramer P
    J Mol Biol; 2005 Jul; 350(5):833-42. PubMed ID: 15979093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Walleye dermal sarcoma virus cyclin interacts with components of the mediator complex and the RNA polymerase II holoenzyme.
    Rovnak J; Quackenbush SL
    J Virol; 2002 Aug; 76(16):8031-9. PubMed ID: 12134008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation.
    Coleman ML; Marshall CJ; Olson MF
    EMBO J; 2003 May; 22(9):2036-46. PubMed ID: 12727871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome.
    Touitou R; Richardson J; Bose S; Nakanishi M; Rivett J; Allday MJ
    EMBO J; 2001 May; 20(10):2367-75. PubMed ID: 11350925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation.
    Casanovas O; Jaumot M; Paules AB; Agell N; Bachs O
    Oncogene; 2004 Sep; 23(45):7537-44. PubMed ID: 15326477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II.
    Leclerc V; Tassan JP; O'Farrell PH; Nigg EA; Léopold P
    Mol Biol Cell; 1996 Apr; 7(4):505-13. PubMed ID: 8730095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder.
    Schneider EV; Böttcher J; Blaesse M; Neumann L; Huber R; Maskos K
    J Mol Biol; 2011 Sep; 412(2):251-66. PubMed ID: 21806996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
    Sheaff RJ; Singer JD; Swanger J; Smitherman M; Roberts JM; Clurman BE
    Mol Cell; 2000 Feb; 5(2):403-10. PubMed ID: 10882081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the G1 phase of the cell cycle by periodic stabilization and degradation of the p25rum1 CDK inhibitor.
    Benito J; Martín-Castellanos C; Moreno S
    EMBO J; 1998 Jan; 17(2):482-97. PubMed ID: 9430640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cyclin C/Cdk8 kinase.
    Leclerc V; Léopold P
    Prog Cell Cycle Res; 1996; 2():197-204. PubMed ID: 9552396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The yeast C-type cyclin Ctk2p is phosphorylated and rapidly degraded by the ubiquitin-proteasome pathway.
    Hautbergue G; Goguel V
    Mol Cell Biol; 1999 Apr; 19(4):2527-34. PubMed ID: 10082518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles for Mediator Cdk8 module subunits in Drosophila development.
    Loncle N; Boube M; Joulia L; Boschiero C; Werner M; Cribbs DL; Bourbon HM
    EMBO J; 2007 Feb; 26(4):1045-54. PubMed ID: 17290221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C.
    Tassan JP; Jaquenoud M; Léopold P; Schultz SJ; Nigg EA
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8871-5. PubMed ID: 7568034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin C influences the timing of mitosis in fission yeast.
    Banyai G; Szilagyi Z; Baraznenok V; Khorosjutina O; Gustafsson CM
    Mol Biol Cell; 2017 Jul; 28(13):1738-1744. PubMed ID: 28515143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.